Why we do what we do: the purpose and impact of guidelines” was the title of the G-I-N Conference 2018. GIN stands for Guidelines International Network. The G-I-N Conference took place in Manchester, United Kingdom, from 11th to 14th September 2018.
Katy Harisson of HARMONY Partner NICE presented a poster about 15 years of hematological malignancies outcome reporting to NICE: data for outcome sets.
Click on the image below to open the abstract >
G-I-N conferences provide the opportunity for discussions on a wide range of issues including the benefits of guidelines for patients and how they can support shared decision making, to addressing variations in care. These unique events are an valuable for all those who work with guidelines in health and care to come together; from development and methodology through to implementation and evaluation.
Relevant links:
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
